Boston Scientific

Welcome to the 'Boston Scientific' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Boston Scientific'.

Latest blogosphere posts tagged “Boston Scientific”

• (VOLC) Volcano Corporation Beats Analyst Estimates

  
  Stock Blog Hub — Authority: 506
  Volcano Corporation ( VOLC ) reported a net loss of 5 cents in the third quarter, narrower than the Zacks Consensus Estimate for a net loss of 12 cents. Although third-quarter revenues increased 22% from the year-ago period, earnings declined from last year’s profit of one penny, mainly due to higher operating ...
  2 days ago

• ($AMMD) American Medical Systems Holdings Reports Strong

  
  Stock Blog Hub — Authority: 506
  American Medical Systems Holdings, Inc. ( AMMD ) reported strong fiscal third quarter results. For the quarter, earnings per share was 27 cents, beating the Zacks Consensus Estimate of 20 cents and the year-ago earnings of 18 cents. Earnings per share for the reported quarter were also ahead of the company’s ...
  3 days ago

• (SRDX) SurModics Misses Earnings Estimates

  
  Stock Blog Hub — Authority: 506
  SurModics ’ ( SRDX ) fourth-quarter earnings per share came in at 18 cents, below the Zacks Consensus Estimate of 20 cents. The company reported revenues of $19.2 million, down 17% compared to the year ago period. In addition to quarterly results, SurModics came out with fiscal year 2009 results. The company ...
  3 days ago

• What Are Best Companies for Health Products and Services for Investing?

  
  Aging Parents Authority — Authority: 116
  What are the best companies that specialize in health products, drugs and services that we can invest in? Are there companies out there which will actually excel and make money in the future? Several health stock analysts have supplied their lists. Granted, we are not giving investment advice, but we think ...
  5 days ago

• Holy $VKNG!

  
  CollegeStock - The Dean of College Stocks — Authority: 139
  The Dean alerted the CollegeStock Community’s attention to $VKNG on Friday, after the stock had made a run of about 1500% in 3 trading days.Earlier today, The Dean followed up with the CollegeStock Community about $VKNG to let them know that he had done his homework and even made an effort to contact $VKNG and [...]
  1 week ago

• The Dean’s Follow Up on $VKNG

  
  CollegeStock - The Dean of College Stocks — Authority: 139
  On Friday, The Dean questioned, “What’s Going on with $VKNG?” because the stock was trading insane volume and increased as much as 1500% towards the end of last week on absolutely no news.Friday, $VKNG closed up more than 100% but fell as much as 40% yesterday with profit taking, before closing 30% in the red. ...
  1 week ago

• QuantumCor Sees Future of Heart Failure Treatment in No Device Left Behind

  
  Xconomy — Authority: 712
  Biotech , Devices , Heart Failure Luke Timmerman wrote: The leading edge of innovation in medical devices is often concentrated on nifty implantable tools that a doctor can insert without a scalpel, as a less-invasive alternative to surgery. But now we’re seeing more startups, like Bothell, WA-based ...
  1 week ago

• What’s Going on with $VKNG?

  
  CollegeStock - The Dean of College Stocks — Authority: 139
  If you haven’t noticed it already, The Dean wants the CollegeStock Community to take a look at Viking Systems (OTC: VKNG).$VKNG develops, manufacturers and markets visualization solutions for minimally invasive surgery.This stock is up more than 120% today and more than 1500% since yesterday morning.Aside from ...
  1 week ago

• (EVVV) ev3 Beats Consensus Earnings Estimates

  
  Stock Blog Hub — Authority: 506
  ev3, Inc. ( EVVV ), the Zacks Bull of the Day for last Friday (October 23rd), reported third quarter 2009 earnings per share of 17 cents, easily beating the Zacks Consensus Estimate of 2 cents and the year-ago earnings of 4 cents. Sales Net sales in the reported quarter increased 5.4% year over year to $112.8 ...
  2 weeks ago

• Krucoff: Second-Generation Drug-Eluting Stents Better at Anti-Restenosis

  
  advanced medical technologies — Authority: 128
  The improvements in stent flexibility and biocompatibility have lead to the conclusion by Dr. Mitchell Krucoff that second-generation drug eluting-stents, such as Abbotts Xience stent, result in an improved ability to prevent restenosis following angioplasty and stent implantation. See an excerpt from Indias ...
  2 weeks ago

• (BCR) C.R. Bard Surpasses Consensus Estimates

  
  Stock Blog Hub — Authority: 506
  C.R. Bard, Inc. (BCR) yesterday reported strong third quarter fiscal 2009 results after the market close. Earnings per share were $1.31, surpassing the Zacks Consensus Estimate of $1.27 and the year-ago earnings of $1.09. Sales Net sales in the quarter increased 3% year over year to $637.0 million. Excluding an ...
  2 weeks ago

• (MDT) Medtronic Starts Erectile Dysfunction Drug-Eluting Device Study

  
  Stock Blog Hub — Authority: 506
  Medtronic, Inc. (MDT) recently started a feasibility study of an interventional treatment for erectile dysfunction (ED) using a specially designed drug-eluting stent system. The study is known as ZEN (Zotarolimus-Eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males with Sub-Optimal ...
  3 weeks ago

• (BSX) Boston Scientific Corporation Surpasses Estimates

  
  Stock Blog Hub — Authority: 506
  Boston Scientific Corporation (BSX) yesterday reported financial results for the third quarter of fiscal 2009 after the market close. Earnings per share were 19 cents, beating the Zacks Consensus Estimate by 5 cents and the year-ago earnings by 3 cents. Sales Net sales in the quarter were $2.0 billion, ...
  3 weeks ago

• Boston Scientific’s Return to Profit is More Bitter Than Sweet

  
  Wall Street Pit — Authority: 647
  Medical device maker Boston Scientific (BSX) reported third quarter earnings which showed the company swung back to a profit. Net income came in at $200 million or 12 cents per share after backing out one-time charges, which obviously compares favorably to the period a year ago where they lost $62...
  3 weeks ago

• Boston Scientific’s Return to Profit is More Bitter Than Sweet

  
  The Razor's Edge — Authority: 132
  Medical device maker Boston Scientific ( BSX ) reported third quarter earnings which showed the company swung back to a profit.  Net income came in at $200 million or 12 cents per share after backing out one-time charges, which obviously compares favorably to the period a year ago where they lost $62 million as ...
  3 weeks ago

• Notable Analyst Rating Changes for 10/20: BAC, AMZN, F, BBT, DTE...

  
  Business Finance & Economy - business.marc8.com — Authority: 163
  UPGRADES: RBC Capital upgrades Bank of America (NYSE: BAC) from Sector Perform to Outperform. Click here for more color. Oppenheimer resumes coverage on Amazon.com (Nasdaq: AMZN), also upgrading the stock from Perform to Outperform. Click Here for more color. read more
  3 weeks ago

• Boston Scientific Posts Profit

  
  Bizzia — Authority: 141
  Medical-devices company Boston Scientific has posted a third-quarter profit, returning to profitability from a quarterly loss a year ago. However, Boston Scientific posted a growth in sales that was less than Wall Street expected as the market for heart-rhythm devices continues to weaken as the economic downturn ...
  3 weeks ago

• Boston Scientific Posts Profit, but Weak Outlook

  
  NYT > Theater — Authority: 913
  Boston Scientific, the medical device maker, said it returned to a profit in the third quarter as sales of its heart implants held up in spite of hospital cutbacks.
  3 weeks ago

• FDA Reiterates Position, Apps Keep on Coming

  
  DeviceTalk — Authority: 125
  Brian Fitzgerald, deputy director of FDA’s Division of Software and Electrical Engineering, was also a panelist at USC’s Body Computing 3.0 conference. He was peppered with questions about how FDA would regulate some of the technology being discussed. Fitzgerald said that innovations in the medical device space ...
  4 weeks ago

• Medical Device Startups Getting Squeezed by Recession, Lawmakers, Says E&Y Report

  
  Xconomy — Authority: 712
  Biotech , Devices , startups Luke Timmerman wrote: People who make a living creating innovative medical devices—whether it’s an ultrasound diagnostic tool, a stent to prop open clogged arteries, or an MRI machine—are an unhappy bunch these days. Let us count the ways, as described in the second ...
  4 weeks ago

Comments about Boston Scientific